What is a Trial Medicine

Trial Medicine – Overview

Trial Medicine refers to the field of medicine that deals with clinical trials. It is a process to determine the efficacy of medicines.

The clinical trial involves a team including biomedical scientists, researchers, and medical doctors.

The process also involves continuous monitoring of the patients receiving the treatments of the new drugs.

The studies assess the effects of a particular drug on specific diseases under investigation.

Who performs Medicine Trials?

Medicine Trials are performed by healthcare professionals and scientists under the government’s health agency.

Medicines are tested in clinical trials on a large number of volunteers. Various government and private entities can conduct clinical trials of new drugs.

Types of Government Health Agencies for Clinical Trials

The following government health agencies can conduct clinical trials of new medicines.

  • National Institutes of Health
  • Researchers
  • Scientists
  • Doctors of Medical Institutes
  • Private Industries with Volunteers
  • Independent Researchers

Who gets the Medicine Trials?

Medicine Trials are performed on volunteers. Generally, volunteers are recruited by Government agencies. However, in some cases, the same agencies pay Volunteers for the clinical trials.

Medicine Trials require continuous trials on a large number of volunteers.

For that reason, the agencies are always looking for volunteers who allow clinical trials on their bodies. Clinical trials involve professional doctors from government health agencies.

The volunteers get paid depending on the research subjects and the size of the research projects. Some research programs are performed in local communities that pay nothing to the volunteers.

Clinical trials are subject to risk assessments, and volunteer compensation varies based on the trial’s demands and potential risks.

How Do Trial Medicines Get an Approval

Trial Medicines reports need to be submitted by the Government Agencies to the Food and Drug Administration Department i.e. the FDA Department.

Based on the clinical trial reports and outcomes, regulatory bodies like the FDA determine the approval of the treatments or medicines tested.

Since Government Agencies are involved, they have to check the pros and cons of the new medicines. The side effects are also monitored by the agencies

All drugs can have side effects, and clinical trials, often regulated by government agencies, evaluate these effects, including potential long-term side effects.

They also generate reports on experimental drugs, regular drugs, and the drugs that are being given to the volunteers for a particular clinical trial program.

How do government agencies acquire Volunteers?

Volunteers are the backbone of Trial Medicine. Without volunteers, the clinical trials of new medicines would not be conducted. There will be no improvement in the healthcare industry.

Some patients believe that new treatments will cure their diseases faster. They are given all the information about the new treatments and the drugs and the side effects associated with them.

After they agree, the agency will ask them to fill up the application form and that’s how they acquire volunteers for their new drug trials.

Besides this, patients suffering from Cancer and AIDS are also asked to join the clinical trial program by the Government Agency.

What are the Outcomes of Trial Medicines?

If we talk about the possible outcomes from trial medicines, then the outcomes can be categorized into four different categories.

For your convenience, we have enlisted all the possible outcomes here:

  1. Positive: If the result of the trial medicines is more effective than the present drugs or treatments, then the outcome for this particular trial medicine is Positive. The chances of getting FDA approval for these medicines and treatments are high as they show positive data with fewer side effects.
  2. Non-inferior: If the result of the new trial medicines matches with the standard treatment and efficacy, then the outcome is non-inferior.
  3. In-conclusive: This outcome represents that the drugs or the treatment performed by the medical professionals have neither a positive outcome nor a non-inferior outcome. This type of trial receives mixed results from the volunteers.
  4. Negative: Negative outcomes mean the trial medicines or treatments are less effective than the standard treatments.

Take Away!

Trial Medicine involves many factors, including the risks and benefits associated with the new drugs and treatments.

If the list of benefits is much higher than the list of risks, the researchers would first research how to reduce the risk factors associated with the new drugs or treatments.

As noted above, trial medicines can have four outcomes. The treatments will be ready for public use if the phase gets positive results.

If the agency is asked to perform further tests, the approval may take several weeks! Medicine Trials are ongoing processes, so there will be mixed reviews from the agencies.

See Also

Phase 1 Clinical Trials

Phase 2 Clinical Trials

Phase 3 Clinical Trials

Phase 4 Clinical Trials

Grants for Dental Implants

Current Version
September 11, 2021
Written By
April 14, 2024
Updated By
Daniyal Haider, MD

Follow us